General Information
Revision date
2021-03-17
Product name
NovoSeven RT, Coagulation Factor VIIa (Recombinant)
1.2.2. Uses advised against
None known
Emergency telephone
+1-800-727-6500
Icons in SDS
Company Information
company name
Novo Nordisk Inc
GHS Information
Signal word
Not
Section 2
2.1 Classification of the substance or mixture
Appearance: Granulate This material is not classified as hazardous under U.S. OSHA regulations (29CFR 1910.1200) (Hazcom 2012) and Canadian WHMIS regulations (Hazardous Products Regulations) (WHMIS 2015). This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. Your needs may vary depending upon the potential for exposure in your workplace. The precautionary statements, warnings and hazards included herein may not apply in all cases, such as when the product or device is in its final form and being used to treat the approved medical condition(s) while under the care of a licensed medical professional and in accordance with the FDA-approved Prescribing Information. Refer to FDA-approved Prescribing Information for final marketed products with regard to special storage, handling and administration requirements in the clinical setting.
Hazard pictograms
None required under U.S. OSHA Hazcom 2012 and Canadian WHMIS 2015 regulations.
Signal word
Not required
Hazard statements
Not required
Precautionary statements
Not required
Other hazards which do not result in classification
Pharmaceutical drug, use according to package insert